Pharmaceutical Nanotechnology

394 papers and 3.2k indexed citations i.

About

The 394 papers published in Pharmaceutical Nanotechnology in the last decades have received a total of 3.2k indexed citations. Papers published in Pharmaceutical Nanotechnology usually cover Pharmaceutical Science (168 papers), Biomaterials (93 papers) and Molecular Biology (82 papers) specifically the topics of Advanced Drug Delivery Systems (108 papers), Advancements in Transdermal Drug Delivery (89 papers) and Nanoparticle-Based Drug Delivery (76 papers). The most active scholars publishing in Pharmaceutical Nanotechnology are Kamal Dua, Ijeoma F. Uchegbu, Andreas G. Schätzlein, Heni Rachmawati and Manish Kumar.

In The Last Decade

Fields of papers published in Pharmaceutical Nanotechnology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pharmaceutical Nanotechnology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pharmaceutical Nanotechnology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pharmaceutical Nanotechnology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pharmaceutical Nanotechnology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025